These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17644545

  • 1. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.
    Ann Rheum Dis; 2008 Jun; 67(6):823-8. PubMed ID: 17644545
    [Abstract] [Full Text] [Related]

  • 2. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.
    Güler-Yüksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Groenendael JH, Mallée C, de Bois MH, Breedveld FC, Dijkmans BA, Lems WF.
    Ann Rheum Dis; 2009 Mar; 68(3):330-6. PubMed ID: 18375540
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density.
    Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lems WF.
    Ann Rheum Dis; 2004 Dec; 63(12):1576-80. PubMed ID: 15547081
    [Abstract] [Full Text] [Related]

  • 4. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U, Teichmann J, Müller-Ladner U, Strunk J.
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [Abstract] [Full Text] [Related]

  • 5. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C, Karlsson M, Akesson K, Jacobsson L.
    Scand J Rheumatol; 2008 Dec; 37(4):248-54. PubMed ID: 18612924
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 7. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years.
    Haugeberg G, Ørstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK.
    Arthritis Rheum; 2002 Jul; 46(7):1720-8. PubMed ID: 12124854
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I.
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [Abstract] [Full Text] [Related]

  • 11. Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial.
    de Jong Z, Munneke M, Lems WF, Zwinderman AH, Kroon HM, Pauwels EK, Jansen A, Ronday KH, Dijkmans BA, Breedveld FC, Vliet Vlieland TP, Hazes JM.
    Arthritis Rheum; 2004 Apr; 50(4):1066-76. PubMed ID: 15077288
    [Abstract] [Full Text] [Related]

  • 12. A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.
    Marotte H, Pallot-Prades B, Grange L, Gaudin P, Alexandre C, Miossec P.
    Arthritis Res Ther; 2007 Apr; 9(3):R61. PubMed ID: 17597527
    [Abstract] [Full Text] [Related]

  • 13. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
    Briot K, Gossec L, Kolta S, Dougados M, Roux C.
    J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
    [Abstract] [Full Text] [Related]

  • 14. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.